Home›Insulin Aspart-Szjj

Insulin Aspart-Szjj

Also known as: Merilog

Insulin Analog

Route: Intravenous, Subcutaneous

Check Insulin Aspart-Szjj Interactions →

37 interactions on record

Insulin Aspart-Szjj has 37 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Albuterol, Alcohol, Angiotensin Ii. Patients taking Insulin Aspart-Szjj should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 37
Moderate: 35

Moderate (35)

Insulin Aspart-Szjj + Albuterol— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Alcohol— May increase or decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required…
Insulin Aspart-Szjj + Angiotensin Ii— May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Clonidine— May increase or decrease blood glucose lowering effect and blunt signs/symptoms of hypoglycemia. Increased glucose monit…
Insulin Aspart-Szjj + Clozapine— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Corticosteroids— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Danazol— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Disopyramide— May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Diuretics— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Epinephrine— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Estrogens— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Fibrates— May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Fluoxetine— May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Glucagon— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Guanethidine— May blunt signs and symptoms of hypoglycemia. Increased glucose monitoring may be required.
Insulin Aspart-Szjj + Isoniazid— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Lithium— May increase or decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required…
Insulin Aspart-Szjj + Macrolide Antibiotics— May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Mao Inhibitors— May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Monoamine Oxidase Inhibitors (Maois)— May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Niacin— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Nonselective Beta-Adrenergic Antagonists— May increase or decrease blood glucose lowering effect and blunt signs/symptoms of hypoglycemia. Increased glucose monit…
Insulin Aspart-Szjj + Octreotide— May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Olanzapine— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Oral Contraceptives— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Pentamidine— May cause hypoglycemia sometimes followed by hyperglycemia. Dose adjustment and increased glucose monitoring may be requ…
Insulin Aspart-Szjj + Pentoxifylline— May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Phenothiazines— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Pramlintide— May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Protease Inhibitors— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Reserpine— May blunt signs and symptoms of hypoglycemia. Increased glucose monitoring may be required.
Insulin Aspart-Szjj + Salicylates— May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Somatropin— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Terbutaline— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Insulin Aspart-Szjj + Thyroid Hormones— May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Albuterol🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Alcohol🟡Moderate

May increase or decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Angiotensin Ii🟡Moderate

May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Clonidine🟡Moderate

May increase or decrease blood glucose lowering effect and blunt signs/symptoms of hypoglycemia. Increased glucose monitoring required.

Insulin Aspart-Szjj + Clozapine🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Corticosteroids🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Danazol🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Disopyramide🟡Moderate

May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Diuretics🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Epinephrine🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Estrogens🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Fibrates🟡Moderate

May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Fluoxetine🟡Moderate

May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Glucagon🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Guanethidine🟡Moderate

May blunt signs and symptoms of hypoglycemia. Increased glucose monitoring may be required.

Insulin Aspart-Szjj + Isoniazid🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Lithium🟡Moderate

May increase or decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Macrolide Antibiotics🟡Moderate

May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Mao Inhibitors🟡Moderate

May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Monoamine Oxidase Inhibitors (Maois)🟡Moderate

May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Niacin🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Nonselective Beta-Adrenergic Antagonists🟡Moderate

May increase or decrease blood glucose lowering effect and blunt signs/symptoms of hypoglycemia. Increased glucose monitoring required.

Insulin Aspart-Szjj + Octreotide🟡Moderate

May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Olanzapine🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Oral Contraceptives🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Pentamidine🟡Moderate

May cause hypoglycemia sometimes followed by hyperglycemia. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Pentoxifylline🟡Moderate

May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Phenothiazines🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Pramlintide🟡Moderate

May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Protease Inhibitors🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Reserpine🟡Moderate

May blunt signs and symptoms of hypoglycemia. Increased glucose monitoring may be required.

Insulin Aspart-Szjj + Salicylates🟡Moderate

May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Somatropin🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Terbutaline🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Thyroid Hormones🟡Moderate

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Insulin Aspart-Szjj + Acetazolamideℹ️Unknown

Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics. Drugs that may increase the risk of hypoglycemia: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics ( 7 ).

Insulin Aspart-Szjj + Somatostatinℹ️Unknown

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.